Recent Headlines
Arteric a Sponsor of Digital Pharma West
Digital Marketing Agency Continues Support of Major Healthcare Conference - June 07, 2017 - Arteric
Pulmotect Convenes Inaugural Scientific Advisory Board
Pulmotect, Inc., a clinical-stage biotechnology company developing and commercializing a fast-acting inhalant designed to treat respiratory infections, today announced the formation of a Scientific Advisory Board comprised of academic and industry experts in respiratory research and care. Members... - June 02, 2017 - Pulmotect, Inc
CrystalGenomics and Standigm, Agree to Collaborate on Utilizing Artificial Intelligence and Structure-Based Drug Design Technologies in Drug R&D
CrystalGenomics, Inc. (KOSDAQ: 083790) and Standigm, Inc., today announced the collaborative partnership to apply Artificial Intelligence (AI) to the research and development of novel drugs. Under the agreement, both parties plan to work together by combining the power of Standigm’s AI... - June 01, 2017 - CrystalGenomics, Inc.
Arteric President and Co-Founder Hans Kaspersetz to Judge 2017 MM&M Awards
Veteran Digital Strategist and SEO Authority Will Serve as In-person Juror - May 31, 2017 - Arteric
Kristen Giordano Joins Arteric as Interactive Art Director
Arteric Expands Creative Services Team with Veteran Pharma Designer. - May 24, 2017 - Arteric
Pulmotect Selected to Exhibit at 2017 BIO International Convention “Innovation Zone”
Pulmotect, Inc., a clinical-stage biotechnology company developing and commercializing an inhalant designed to treat respiratory infections, was selected by the National Science Foundation (NSF) and the National Institutes of Health (NIH) to be featured in an Innovation Zone at the 2017 BIO... - May 20, 2017 - Pulmotect, Inc
Nicole Ventura Joins Arteric as Account Executive
Arteric Expands Client Services Team With Seasoned Pharma Veteran. - May 17, 2017 - Arteric
Stelis Biopharma Partners with Merck
Stelis Biopharma, a fully-integrated biopharmaceutical company with capabilities in providing global contract development and manufacturing services, and Merck a premier supplier of solutions and services to the global life science industry, today announced the opening of its Joint Process Scale-Up Lab at the Stelis Biopharma R&D facility in Bengaluru. The lab, which was built as a centre of excellence for bioprocess scale-up and manufacturing services, represents the strength of the two groups. - May 14, 2017 - Stelis Biopharma
MoBiTec to Offer the First Commercially Available Bacillus Subtilis Food Grade Expression System
The Bacillus Food Grade Expression System was created to make the advantages of a Bacillus expression system also accessible to areas where antibiotic resistance gene markers are prohibited (e.g., food and feed industry). - May 11, 2017 - MoBiTec GmbH
US China Innovation and Investment Summit Panel on Biopharmaceuticals to Feature Pulmotect CEO
Molfino, a respiratory medicine specialist, will provide his perspective on balancing the costs of developing and delivering innovative technologies, drug safety and regulatory issues, important learnings to date and the future outlook of therapeutics in modern healthcare. - May 10, 2017 - Pulmotect, Inc
Arteric Technology Utilized in Hypertension Medication Adherence Study at Baylor College of Medicine
OnTimeRx® Automated Reminder Service Tested in Stroke Prevention Program Targeting African-American Women. - May 08, 2017 - Arteric
Arteric President and Founder Hans Kaspersetz Featured in Life Science Marketing Podcast
Veteran SEO Speaker and Panelist Discusses Foundational and Leading-Edge SEO Tactics for Life Science and Biotech Marketers - May 08, 2017 - Arteric
Simultaneous Heterologous Gene Expression in Bacillus Megaterium: Vector p3STOP1623-2RBShp
Optimized high performance (hp) vectors for Bacillus megaterium - MoBiTec provides a wide range of useful vectors for the Bacillus megaterium system, including a vector with two ribosome binding sites (2RBS) for simultaneous dual expression. - May 05, 2017 - MoBiTec GmbH
Virun® Strikes a Nerve at Ingredient Marketplace in Orlando, and Launches New, Novel and Highly Informative Website; STATIC 3 Filming Underway
Virun® NutraBiosciences® Gives Probiferrin™ Its’ Coming Out Party and Garners the Attention of Millennial Movers and Shakers; New Virun Website Showcases Innovative Mantra and Formulation Expertise; STATIC 3 Coming Soon to a Mosh-Pit Near You - May 02, 2017 - VIRUN
New Research Identifies Need for Patient-Centric Clinical Trials and Role for CROs
New Research Identifies Patient-centric Strategies for Clinical Development with over 125 Global Research Opinion Leaders. - April 28, 2017 - Life Science Strategy Group, LLC
New Microplate-Based Method to Measure OCR and ECA Under Steady-State [O2]
Cayman Chemical, in collaboration with BMG LABTECH GmbH, has developed a novel assay kit to measure mitochondrial function under a dynamic range of oxygen concentrations. The Mito Stress Test (ACU Format) is designed to measure oxygen consumption rate (OCR) and extracellular acidification (ECA)... - April 26, 2017 - Cayman Chemical Company
The NHLBI Grants NuvOx Pharma a 300K Grant to Study the Effects of Their Oxygen Therapeutic on Myocardial Infarction in a Pig Model
The National Heart, Lung, and Blood Institute (NHLBI) has awarded a grant for $317,743 for a study in pigs for NuvOx Pharma's drug, NVX-308, in heart attack. - April 14, 2017 - NuvOx Therapeutics
MiTeGen Opens NANUQ Access Facility
MiTeGen LLC, a provider of innovative consumables and equipment for protein crystallization and single crystal X-ray, announced the opening of the NANUQ Access Facility (NAF) which provides scientists with day-use access to MiTeGen’s revolutionary automated high-speed cryocooling device (NANUQ). - April 12, 2017 - MiTeGen, LLC
MoBiTec GmbH to Attend LABVOLUTION/ BIOTECHNICA, May 16-18, 2017, Hannover, Germany
LABVOLUTION with BIOTECHNICA is a fully integrated event that provides a multidisciplinary perspective on all aspects of the laboratory world. Don't miss Northern Europe's leading business platform for laboratory technology and biotechnology. - March 31, 2017 - MoBiTec GmbH
Jivana Biotechnology Inc, is Pleased to Announce the Addition of Dr. Ajay Maker to Its Advisory Committee
Dr. Maker brings surgical oncology experience with expertise in liver, gallbladder. colon, pancreatic, and other cancers to Jivana Biotechnology's advisory committee. - March 16, 2017 - Jivana Biotechnology Inc
AdvantaPure(R) Launches AdvantaSil(TM) Brand of Silicone Tubing and Hose
AdvantaPure has rebranded its silicone tubing and reinforced hose under the AdvantaSil name. The products, used primarily for biopharm and pharmaceutical Single-Use processes, have been depended upon by design engineers for years. AdvantaSil products include unreinforced tubing, reinforced hose, pump grade tubing and wire reinforced suction hose. - March 16, 2017 - AdvantaPure
Novel Lipid Research Assay: Lysosomal PLA2 Inhibitor Screen
Inhibition of Lysosomal phospholipase A2 (LPLA2) by a drug candidate can predict its potential to cause drug-induced phospholipidosis, a serious side effect resulting in tissue inflammation and organ damage. - March 11, 2017 - MoBiTec GmbH
Kemwell Announces Successful USFDA Inspection at Bangalore Facility
Kemwell Biopharma, a global bio/pharmaceutical contract development and manufacturing company, announced today that its oral solids manufacturing facility located in Bangalore, India has successfully completed a U.S. Food and Drug Administration (USFDA) inspection. The inspection confirmed the... - February 19, 2017 - Kemwell Biopharma Private Limited
Virun® Releases STATIC™ Episode 2 While Under the Influence of Sulfur Hexaflouride, and New Probiotic Technology Makes Wholefoods Take Notice
Virun® NutraBiosciences® Ongoing Video Series Explores the Smells of Stability and Voice-changing Gases; Virun’s Patent & Patents-pending Non-refrigerated Shelf-stable Probiotics Become Available to Manufacturers Worldwide - February 14, 2017 - VIRUN
NuvOx Pharma and Jiangsu Nhwa Pharmaceutical Co., Ltd. Sign Licensing Agreement for Hemorrhagic Shock and Perioperative Blood Loss
NuvOx Pharma LLC and Jiangsu Nhwa Pharmaceutical Co., Ltd. have signed a licensing agreement for the exclusive development and sales of NVX-408 for China for treating hemorrhagic shock and perioperative blood loss. NVX-408 is an oxygen therapeutic that is injected intravenously, flows through the... - January 26, 2017 - NuvOx Therapeutics
The Zoozler Venture Network is Looking for an Idea
You have a fantastic idea for a product or service but you don't know how to go about making it a reality. You know that you'll need investors but how do you get to them? That's where the Zoozler Venture Network can help. The Zoozler Venture Network will take the idea and help make it into a successful reality. - January 13, 2017 - Zoozler
Life Science Leader and ClinicalLeader.com Announce New Forum for Small to Mid-Sized Pharma and Biotech Companies
Life Science Leader and ClinicalLeader.com are excited to introduce Clinical Leader Forum, a new conference tailored just for executives at pharma and biotech sponsor companies that rely on contract research organizations for clinical trials. The inaugural event is scheduled for May 10 through 11... - December 07, 2016 - Clinical Leader Forum
New Research Explores Wearable Technology Utilization in Clinical Trials and the Role of CROs
New Report Identifies Current and Future Wearable Technology Utilization and CRO Implications with 130 Clinical Outsourcing Decision Makers. - December 01, 2016 - Life Science Strategy Group, LLC
Research to be Presented at ASH Annual Meeting Shows Verseon’s New Class of Anticoagulants Prevents Thrombosis While Preserving Platelet Function
Verseon’s anti coagulants are as effective as NOACS at preventing arterial and venous thromboembolism and thrombin-induced pulmonary embolism. Lead candidate has low renal clearance compared to NOACS - highly desirable for patients with impaired renal function. - November 30, 2016 - Verseon
Gensco Pharma Announces ColciGel®, a New Transdermal Medication Indicated for the Treatment of Acute Gout Flares in Adults
A new transdermal gel has been developed and is now available by prescription only to treat the symptoms of gout attacks. ColciGel® is a transdermal medication that provides rapid relief of pain at the first sign of acute gout flares without gastrointestinal problems. - November 22, 2016 - Gensco Pharma
Astero®, Manufactured by Gensco Laboratories, is the Only FDA Approved Prescription Hydrogel with Topical Anesthetic, Indicated for Painful Wounds
Astero® is indicated for painful wounds such as stage I-IV pressure ulcers, Venous stasis ulcers, ulcerations caused by mixed vascular etiologies, Diabetic skin ulcers, first and second degree burns, post-surgical incisions, cuts and abrasions. Astero® is specifically formulated to create a moist healing environment, which promotes granulation, epithelialization, and autolytic debridement, while providing prolonged anesthesia of the wound, lessening the need for systemic pain medications. - November 19, 2016 - Gensco Pharma
Virun® Launches a Line of Shelf-Stable Probiotic Multi-Serving Powders and Emulsions
Virun® NutraBiosciences® Technology Revolutionizes Probiotics with Non-refrigerated Probiotic Single-serving Powders and Emulsions Available to Manufacturers. - November 15, 2016 - VIRUN
NuvOx Pharma Awarded NIH Grant to Develop Technology to Increase Sensitivity and Specificity of Breast Cancer Diagnosis
NuvOx Pharma, a Tucson based biotechnology company, has been awarded a grant from the National Cancer Institute for $298,820.00 entitled, “B7-H3-Targeted Contrast Agent for Ultrasonic Imaging of Breast Cancer.” Evan Unger, MD, co-founder of NuvOx, a co-principal investigator of the... - November 03, 2016 - NuvOx Therapeutics
New Research Benchmarks Clinical Investigator Satisfaction with Pharma Sponsors and Central Laboratories
5-year Study Tracks Central Lab Performance and Identifies Opportunities for Pharma Sponsors to Improve Clinical Investigator Satisfaction. - October 24, 2016 - Life Science Strategy Group, LLC
Experimentica Ltd. Appoints New Director of In Vivo Pharmacology
Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Tamuna Bolkvadze, Ph.D. to Director In Vivo Pharmacology, effective immediately. Dr. Bolkvadze joined Experimentica Ltd. earlier in 2016 as Research Scientist and has been instrumental... - October 22, 2016 - Experimentica Ltd
Spherium Biomed Starts Efficacy Trial Cyclatop for the Treatment of Atopic Dermatitis in Adults and Infants
The clinical trial is a pilot study (the Cyclatop study) for the evaluation of SP14019-F-01 topical solution for the treatment of atopic dermatitis. It is designed to investigate the safety, tolerability, pharmacokinetics and efficacy of SP14019-F-01 across all group ages for the treatment of mild... - September 29, 2016 - Spherium Biomed
STATIC™ – New Video Broadcast Series Uncovering “The Good, The Bad and the Ugly” of Nutritional Products
Virun® Nutra-BioSciences® Creates New Series of Video Broadcasts Called STATIC, Focusing on Nutrition Found in Finished Products. - September 27, 2016 - VIRUN
Quorum Innovations Announces Availability of Human Microbiome Therapeutics to Treat Common Skin Conditions and Metabolic Disorders
Probiomic Therapeutics™ for Eczema, Atopic Dermatitis, Eosinophilic Esophagitis (EoE), Metabolic Disorders - September 24, 2016 - Quorum Innovations
AUM LifeTech's Self-Delivering FANA Antisense Oligonucleotides to be Distributed by MoBiTec Germany
AUMsilence self-delivering oligos achieve highly efficient and potent antisense-based gene knockdown. No need to use toxic transfection reagents. Especially designed for primary cells and very difficult-to-transfect cell types. - September 24, 2016 - MoBiTec GmbH
For Lentivirus Production: TransIT®-Lenti Transfection Reagent, Available from MoBiTec, Germany
TransIT®-Lenti Transfection Reagent, manufactured by Mirus Bio, US, is designed to enhance delivery of packaging and transfer vectors to adherent HEK 293T cell types and increase recombinant lentivirus production. - September 23, 2016 - MoBiTec GmbH
Batavia Biosciences Receives Grant to Develop New Vaccine Against Rotavirus
Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable rotavirus vaccine to the global health market. This vaccine aims to save many young children’s lives worldwide. - September 21, 2016 - Batavia Biosciences
We All Want to Live in a Yellow Submarine at Virun’s SupplySide West Booth
Go under the sea in a yellow submarine and cast your vote for the next Omega-3 Smoothie - September 15, 2016 - VIRUN
Recursion Pharmaceuticals Receives Fast-Track SBIR Grant to Study Age-Related Disease
Recursion Pharmaceuticals, an exciting biotech company located in the University of Utah’s Research Park, today announced a $223,000 Phase I Small Business Innovation Research award from the National Institutes of Health (NIH) via the National Institute on Aging (NIA). The award, which has... - September 15, 2016 - Recursion Pharmaceuticals
CHI's 8th Annual SCOPE: Summit for Clinical Ops Executives Returns to Miami, January 24-26, 2017
1,200+ Executives to gather for solutions on various aspects of clinical trial planning and management at 13 co-located conferences and 2 symposia - September 13, 2016 - Cambridge Healthtech Institute
CRISPR/Cas9 - Request a Free Sample for Your Genome Editing Research
The use of CRISPR/Cas9 has emerged as a powerful method for genome editing that can be delivered in multiple formats. MoBiTec together with Mirus Bio provide solutions to address delivery of Cas9 and guide RNA in plasmid, RNA, or RNP format. - September 10, 2016 - MoBiTec GmbH
Silicone Suction Hose from AdvantaPure(R) is Now NSF Listed; Provides an Increased Level of Quality Assurance
AdvantaPure’s APSW silicone suction hose now boasts an NSF listing (NSF-51), giving users reassurance for the product’s compatibility with food, beverage and other clean applications. APSW is reinforced with a helical stainless steel wire and layers of fabric and silicone to handle both suction and discharge applications. The hose is available in smooth or convoluted O.D. styles, withstands temperatures up to 350 degrees F, and may be sterilized using several different methods. - September 02, 2016 - AdvantaPure
Dextra UK Launched the World's Largest Commercial Glycan Array, Marketed in Germany and Other Countries Through Its Authorized Distributor MoBiTec GmbH
Dextra's Glycan Array Kit is a valuable tool for use in determining the glycan binding profile of proteins, eukaryotic cells, viruses, spores, bacteria, and parasites. It features 104 unique glycans carefully selected from cutting-edge libraries. - September 02, 2016 - MoBiTec GmbH
NuvOx Pharma Awarded NIH Grant to Develop Technology to Treat Endocarditis
NuvOx Pharma, a Tucson based biotechnology company, has been awarded a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health for $243,164.00 entitled, “Fibrin Targeted Microbubbles and Ultrasound for... - August 27, 2016 - NuvOx Therapeutics
PBTF Unites with We Can to Form California Chapter
The We Can Pediatric Brain Tumor Network is now the California Chapter of the Pediatric Brain Tumor Foundation. - August 25, 2016 - Pediatric Brain Tumor Foundation
FDA Allows NuvOx Pharma’s IND to Initiate Phase Ib Clinical Trial in Stroke
Evan Unger, MD, President and CEO of NuvOx, announced that the FDA has allowed an investigational new drug application (IND) for NVX-208 (dodecafluoropentane emulsion) to be tested in a Phase Ib trial in stroke patients. The trial will be performed at the University of Arkansas Medical System in... - August 22, 2016 - NuvOx Therapeutics